Key Points
1140.HK stock fell 9.1% to HK$0.22 in pre-market trading on HKSE
Meyka AI rates the stock B with neutral hold recommendation based on mixed fundamentals
Technical overbought signals (RSI 69.88, MFI 91.46) suggest consolidation risk near-term
Forecast models project 26% one-year upside to HK$0.278 and 186% five-year potential
1140.HK stock is trading lower in pre-market action on the Hong Kong Stock Exchange. HK.AI Capital Limited, formerly known as Wealthking Investments Limited, saw its share price fall to HK$0.22, down 9.1% from the previous close of HK$0.242. The investment holding company focuses on customized solutions across medical, finance, TMT, and health sectors. With a market cap of HK$2.79 billion and 11.66 billion shares outstanding, 1140.HK stock remains actively traded. Meyka AI’s analysis reveals mixed technical signals as the stock navigates volatile market conditions in early trading.
1140.HK Stock Price Movement and Technical Setup
The 1140.HK stock opened at HK$0.25 before declining sharply to HK$0.22, marking a significant intraday reversal. Today’s range spans from HK$0.216 (day low) to HK$0.25 (day high), showing substantial volatility. The 52-week range reveals broader context: HK$0.071 (year low) to HK$0.28 (year high), indicating the stock has recovered 209% from its annual bottom.
Technical indicators paint a complex picture for 1140.HK stock. The Relative Strength Index (RSI) stands at 69.88, signaling overbought conditions. The Money Flow Index (MFI) reads 91.46, also overbought, suggesting potential pullback risk. However, the Average Directional Index (ADX) measures 35.80, confirming a strong trend is in place. Volume activity reached 10.98 million shares, slightly below the 10.61 million average, indicating moderate participation in today’s decline.
Valuation Metrics and Financial Health of 1140.HK
1140.HK stock trades at a price-to-earnings ratio of 23.9, above the Financial Services sector average of 12.23. The price-to-book ratio of 0.25 suggests the stock trades at a significant discount to book value, a potential value indicator. The enterprise value-to-sales multiple of 10.48 reflects premium pricing relative to revenue generation.
Financial strength metrics show solid fundamentals. The current ratio stands at 6.75, well above the 1.0 threshold, indicating strong liquidity. Debt-to-equity ratio of 0.065 demonstrates conservative leverage. Cash per share totals HK$0.399, providing a cushion for operations. However, the return on equity of 1.1% and return on assets of 1.02% suggest modest profitability relative to capital employed. Track 1140.HK on Meyka for real-time updates on these metrics.
Meyka AI Grade and Market Sentiment Analysis
Meyka AI rates 1140.HK with a grade of B, suggesting a neutral hold recommendation. The overall score of 63.05 reflects balanced risk-reward dynamics. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating details reveal mixed signals: strong buy on price-to-book (score 5), but strong sell on DCF valuation (score 1) and sell recommendations on ROE, debt-to-equity, and PE metrics.
Trading activity shows moderate engagement despite the sharp decline. Volume of 10.98 million shares represents 97.7% of average daily volume, indicating normal participation levels. The stock’s 1-month performance shows a gain of 39.8%, suggesting recent strength before today’s pullback. Liquidation pressure appears contained given the solid current ratio and minimal debt burden. These grades are not guaranteed and we are not financial advisors.
Price Forecasts and Long-Term Growth Outlook
Meyka AI’s forecast model projects 1140.HK stock reaching HK$0.278 within one year, implying 26.4% upside from current levels. The three-year target stands at HK$0.455, representing 106.8% potential appreciation. Five-year projections reach HK$0.630, suggesting 186% upside over the medium term. These forecasts reflect the model’s assessment of growth potential in the investment holding sector.
The stock’s recent performance supports longer-term optimism. Year-to-date gains of 19.5% and one-year returns of 218.7% demonstrate significant momentum. However, the three-year decline of 29.7% highlights cyclical challenges. Forecasts are model-based projections and not guarantees. Investors should consider that Asian stock market dynamics continue to influence Hong Kong-listed securities like 1140.HK stock.
Final Thoughts
1140.HK stock faces near-term headwinds with today’s 9.1% decline, though technical overbought conditions suggest potential consolidation rather than sustained selling. Meyka AI’s B grade and neutral recommendation reflect the stock’s mixed fundamentals: strong balance sheet metrics offset by modest profitability and elevated valuation multiples. The company’s focus on high-growth sectors (medical, finance, TMT, health) provides strategic positioning, yet execution remains critical. Investors should monitor the stock’s ability to hold above HK$0.216 support and watch for volume confirmation of any recovery attempts. The forecast models suggest meaningful upside potential over 12-60 months, but near-term volatility appears likely given overbought technical readings.
FAQs
The decline reflects profit-taking after strong recent gains. Technical indicators show overbought conditions (RSI 69.88, MFI 91.46), suggesting investors locked in gains. Market-wide Asian stock weakness may have also contributed to the pullback in 1140.HK stock.
Meyka AI assigns 1140.HK a grade of B with a neutral hold recommendation. The score of 63.05 reflects balanced fundamentals. The rating combines sector comparison, financial metrics, and analyst consensus. Strong price-to-book metrics contrast with weak DCF and ROE scores.
The price-to-book ratio of 0.25 suggests discount valuation. However, the PE ratio of 23.9 exceeds sector average of 12.23. Modest ROE of 1.1% raises profitability concerns. Value depends on your investment timeline and risk tolerance.
Meyka AI forecasts HK$0.278 within one year (26% upside), HK$0.455 in three years (107% upside), and HK$0.630 in five years (186% upside). These are model-based projections, not guarantees of future performance.
Very strong. Current ratio of 6.75 indicates excellent liquidity. Debt-to-equity of 0.065 shows conservative leverage. Cash per share of HK$0.399 provides operational cushion. However, low ROE and ROA suggest modest capital efficiency.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)